Mokenge Malafa Selected Research

Adenocarcinoma

12/2023	Stereotactic body radiotherapy with or without selective dismutase mimetic in pancreatic adenocarcinoma: an adaptive, randomised, double-blind, placebo-controlled, phase 1b/2 trial.
1/2023	Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-Fraction Ablative Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy (A-SMART).
1/2023	Neoadjuvant chemotherapy and stereotactic body radiation therapy for borderline resectable pancreas adenocarcinoma: influence of vascular margin status and type of chemotherapy.
11/2022	Surgical and Pathologic Outcomes of Pancreatic Adenocarcinoma (PA) After Preoperative Ablative Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy (A-SMART).
1/2022	Phase I Study of Lenvatinib and Capecitabine with External Radiation Therapy in Locally Advanced Rectal Adenocarcinoma.
1/2022	Surgical approach to pancreaticoduodenectomy for pancreatic adenocarcinoma: uncomplicated ends justify the means.
1/2022	Adjuvant Chemoradiotherapy in Resected Pancreatic Ductal Adenocarcinoma: Where Does the Benefit Lie? A Nomogram for Risk Stratification and Patient Selection.
1/2021	Identification of Targetable Gene Fusions and Structural Rearrangements to Foster Precision Medicine in KRAS Wild-Type Pancreatic Cancer.
1/2020	Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice.
10/2017	Cancer Antigen 125 (CA125, MUC16) Protein Expression in the Diagnosis and Progression of Pancreatic Ductal Adenocarcinoma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mokenge Malafa Research Topics

Disease

31	Neoplasms (Cancer) 12/2023 - 01/2006
14	Adenocarcinoma 12/2023 - 10/2007
14	Pancreatic Neoplasms (Pancreatic Cancer) 12/2023 - 02/2011
7	Carcinogenesis 03/2018 - 01/2007
4	Colorectal Neoplasms (Colorectal Cancer) 12/2023 - 01/2007
3	Neoplasms, Cystic, Mucinous, and Serous 01/2023 - 12/2016
3	Disease Progression 07/2021 - 02/2007
3	Stomach Neoplasms (Stomach Cancer) 01/2019 - 12/2011
3	Neoplasm Metastasis (Metastasis) 02/2007 - 01/2006
2	Melanoma (Melanoma, Malignant) 01/2023 - 01/2016
2	Adenoma (Adenomas) 07/2018 - 09/2007
2	Colonic Neoplasms (Colon Cancer) 07/2018 - 01/2007
2	Pancreatic Intraductal Neoplasms 09/2015 - 01/2015
2	Pancreatic Cyst 01/2015 - 01/2015
2	Breast Neoplasms (Breast Cancer) 04/2009 - 07/2006
2	Pathologic Complete Response 04/2009 - 07/2006
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 05/2024
1	Abdominal Pain (Pain, Abdominal) 12/2023
1	Atrial Fibrillation 12/2023
1	Cholangitis 12/2023
1	Colitis 12/2023
1	Duodenal Obstruction 12/2023
1	Fever (Fevers) 12/2023
1	Infections 12/2023
1	Pneumonia (Pneumonitis) 12/2023
1	Respiratory Insufficiency (Respiratory Failure) 12/2023
1	Abdominal Abscess 12/2023
1	Sepsis (Septicemia) 12/2023
1	Acute Kidney Injury (Acute Renal Failure) 12/2023
1	Microsatellite Instability 01/2023
1	Surgical Wound Infection 11/2022
1	Margins of Excision 11/2022
1	Rectal Neoplasms (Rectal Cancer) 01/2022
1	Drug-Related Side Effects and Adverse Reactions 07/2021
1	End Stage Liver Disease 01/2018
1	Cholangiocarcinoma 01/2018
1	Rupture 01/2017
1	Mucocele 01/2017
1	Pseudomyxoma Peritonei 01/2017

Drug/Important Bio-Agent (IBA)

12	Biomarkers (Surrogate Marker)IBA 12/2023 - 02/2007
5	MicroRNAs (MicroRNA)IBA 12/2016 - 02/2011
4	Proteins (Proteins, Gene)FDA Link 07/2018 - 01/2015
3	RNA (Ribonucleic Acid)IBA 12/2023 - 01/2021
3	AntigensIBA 01/2018 - 01/2016
3	triciribineIBA 09/2015 - 09/2007
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2021
2	Capecitabine (Xeloda)FDA Link 01/2022 - 08/2011
2	Hormones (Hormone)IBA 01/2020 - 01/2006
2	Gemcitabine FDA Link 09/2015 - 08/2011
2	Dihydrotachysterol (AT 10)IBA 07/2014 - 01/2014
2	Cytotoxins (Cytolysins)IBA 10/2013 - 04/2009
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2009 - 07/2006
2	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2009 - 07/2006
2	tipifarnib (R115777)IBA 04/2009 - 07/2006
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 10/2007 - 09/2007
2	API 2IBA 10/2007 - 09/2007
1	Immunologic Factors (Immunomodulators)IBA 05/2024
1	NivolumabIBA 12/2023
1	regorafenibIBA 12/2023
1	avasopasem manganeseIBA 12/2023
1	Alkaline PhosphataseIBA 12/2023
1	Lipase (Acid Lipase)FDA Link 12/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 12/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2022
1	First Generation CephalosporinsIBA 11/2022
1	Second Generation CephalosporinsIBA 11/2022
1	lenvatinibIBA 01/2022
1	GenieIBA 01/2021
1	4- (2,6- dichlorobenzoylamino)- 1H- pyrazole- 3- carboxylic acid piperidin-4-ylamideIBA 01/2021
1	Antipsychotic Agents (Antipsychotics)IBA 01/2020
1	Tocopherols (Tocopherol)IBA 01/2020
1	Vitamin E FDA LinkGeneric 01/2020
1	Penfluridol (Semap)IBA 01/2020
1	ProlactinIBA 01/2020
1	TocotrienolsIBA 01/2020
1	Prolactin Receptors (Prolactin Receptor)IBA 01/2020
1	BilirubinIBA 01/2018
1	Yttrium-90IBA 01/2018
1	AlbuminsIBA 01/2018
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2018
1	MucinsIBA 01/2017

Therapy/Procedure

11	Therapeutics 05/2024 - 01/2006
8	Drug Therapy (Chemotherapy) 12/2023 - 04/2009
5	Radiotherapy 01/2023 - 01/2017
2	Neoadjuvant Therapy 01/2023 - 01/2022
2	Immunotherapy 01/2023 - 11/2020
2	Pancreaticoduodenectomy 11/2022 - 01/2022
2	Laparotomy 01/2017 - 11/2015
2	Complementary Therapies (Alternative Medicine) 02/2013 - 01/2006
2	Chemoprevention 02/2013 - 01/2007
2	Cytoreduction Surgical Procedures 02/2007 - 01/2006
1	Stents 11/2022
1	Adjuvant Chemoradiotherapy 01/2022
1	Chemoradiotherapy 01/2022
1	Adjuvant Chemotherapy 01/2022
1	Molecular Targeted Therapy 01/2021
1	Precision Medicine 01/2021
1	Injections 01/2020
1	Microspheres (Microsphere) 01/2018
1	Appendectomy 01/2017